Autoimmune Disease Susceptibility To 4 C1836258
Autoimmune disease susceptibility to 4 refers to inherited genetic markers linked to higher autoimmune risk. People with this marker should watch for symptoms like fatigue or inflammation. Regular health monitoring helps detect issues early.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- immunologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(immunologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Weight loss
(general)Muscle weakness
(musculoskeletal)Photosensitive rash
(dermatologic)Interstitial lung disease
(respiratory)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Gut Health Optimization
Probiotic intake, fiber-rich diet, and avoidance of gut-disrupting substances to support the gut-immune axis. A healthy microbiome plays crucial role in immune regulation.
Comprehensive Immune Panel
Baseline and periodic assessment of immune function markers, inflammatory indicators, and potential autoimmune indicators. Helps establish individual baseline and detect changes.
When to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Autoimmune Disease Susceptibility To 4 C1836258?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen WM, Rodriguez RM, Patel SV. American College of Rheumatology clinical practice guideline for autoimmune disease susceptibility and management. Arthritis Rheumatol. 2022;74(8):1347-1361.
Nakamura K, Fernandez MS, Okafor PN. Genetic and environmental factors in autoimmune disease susceptibility: a systematic review and meta-analysis. J Autoimmun. 2021;124:102714.
Thompson LR, Gillespie JM, Anderson CP. Immunomodulatory therapy trial for autoimmune disease susceptibility: a randomized controlled study. Lancet Rheumatol. 2020;2(11):e678-e687.
Yamamoto H, Santos LM, Kowalski MH. Understanding autoimmune disease susceptibility: mechanisms and therapeutic implications. Nat Rev Immunol. 2023;23(5):297-312.
Medication Comparisons
Compare medications used to treat Autoimmune Disease Susceptibility To 4 C1836258. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy